NASDAQ · ENLV
Enlivex financials
$0.4801−6.60%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Gross margin | — | — | — | — | — | — | — |
| Operating income | -$15.0M | -$15.9M | -$29.4M | -$25.8M | -$19.3M | -$9.8M | -$8.6M |
| Net income | $1.24B | -$15.0M | -$29.1M | -$31.1M | -$14.5M | -$11.8M | -$9.6M |
| Net margin | — | — | — | — | — | — | — |
| Diluted EPS | $382.20 | $-10.95 | $-23.40 | $-25.35 | $-12.15 | $-13.50 | $-16.65 |
| EBITDA | -$14.7M | -$15.3M | -$28.6M | -$25.0M | -$18.7M | -$9.5M | -$8.4M |
| Operating cash flow | -$10.4M | -$13.0M | -$23.5M | -$24.0M | -$17.5M | -$11.0M | -$7.0M |
| Free cash flow | -$30.0M | -$13.1M | -$23.8M | -$32.1M | -$19.2M | -$12.0M | -$7.2M |
| Diluted shares | 3.2M | 1.4M | 1.2M | 1.2M | 1.2M | 0.9M | 0.6M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.9M | $3.3M | $813.0K | $49.9M | $11.2M | $5.7M |
| Short-term investments | $3.9M | $20.4M | $26.5M | $299.0K | $62.9M | — |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $5.4M | $0.00 |
| Total assets | $2.33B | $27.7M | $36.8M | $67.6M | $95.1M | $40.4M |
| Total liabilities | $392.1M | $4.1M | $6.7M | $10.8M | $10.1M | $4.9M |
| Shareholders' equity | $1.93B | $23.6M | $30.1M | $56.8M | $85.0M | $35.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology